CMS proposes nationwide drug prior authorization overhaul, mandates 72-hour turnaround
CMS published a proposed rule targeting prior authorization for drugs under Medicare Advantage, Medicaid Managed Care, and CHIP. The rule would mandate a 72-hour standard turnaround for urgent requests and require payers to provide a specific reason for any denial, including citing clinical criteria. It also proposes electronic prior authorization standards aimed at reducing provider burden. The rule applies broadly to MAOs, Medicaid plans, and QHP issuers. The comment period closes mid-June 2026, with an expected effective date in 2027. Monitor the comment period on CMS-2025-XXXX for final details.